Page 10 - FOOD BANKS: A GROWING DEMAND- by Emma Berry
1 Independent. Food bank use in UK reaches highest rate on record as benefits fail to cover basic costs. 2017. Available at: Accessed 13th September 2018
2 The Trussell Trust. What We Do. 2018. Available at: Accessed on: 13th September 2018 and
3 The Trussell Trust. How Food Banks Work. 2018. Available at: Accessed 13th September 2018
4 Food Poverty Action Aberdeen (FPAA). Food Poverty/Insecurity in Aberdeen. 2017. Available at: Accessed 13th September 2018
5 Community Food Initiatives North East. Improving Health and Well-Being: Business for Community Benefit. 2018. Summary of Activities. Available on request from CFINE
6 Crowdfunder. Tuk In. 2017. Available at: Accessed 13th September 2018
7 Scottish Government. Providing Free Sanitary Products. 2018. Available at: Accessed 13th September 2018
8 Trussel Trust. Annual Reports and Accounts. 2017. Available at: Accessed 13th September 2018
9 Loopstra R, Fledderjohann J, Reeves A, & Stuckler D. Impact of Welfare Benefit Sanctioning on Food Insecurity: a Dynamic Cross-Area Study of Food Bank Usage in the UK. Journal of Social Policy. 2018. 47(3): 437-457
10 Kaur J, Lamb MM, & Ogden C. The Association between Food Insecurity and Obesity in Children – The National Health and Nutrition Examination Survey. Journal of the Academy of Nutrition and Dietetics. 2015.115(5): 751-758
11 HM Government. Guidance: Childhood obesity: a plan for action. 2017. Available at: Accessed 13th September 2018
12 NHS. Healthy Start: How to Apply. 2018. Available at: Accessed 13th September 2018

1 Hardiman O, van den Berg LH and Kiernan MC (2011). Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology, 7 639-649
2 Hobson E, Harwood C, McDermott C, Shaw P (2016). Clinical aspects of motor neurone disease. Spinal cord, nerve, muscle. Medicine 44:9: 552-556
3 Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A. SLALOM Group (2008). Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis; 9 (3): 163-7
4 Renton AE, Majounie E, Waite A et al (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron; 72: 257-68
5 Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E et al (2009). Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 10: 310-23
6 Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P (2000). Nutritional assessment and survival in ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders; 1(2): 91-6
7 Katzberg HD, Benatar M (2001). Enteral tube feeding for amyotrophic lateral sclerosis/motor neurone disease. Cochrane Database of Systematic Reviews, Issue 1
8 Kuhnlein P, Gdynia HJ, Sperfeld AD et al (2008). Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol.4: 366-74
9 Miller RG, Jackson CE, Kasarskis EJ et al (2009). Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology; 73: 1218-26)
10 Heffernan, Jenkinson, Holmes, Feder, Kupfer, Leigh, McGowan, Rio, Sidhu (2004). Nutritional management in MND/ALS patients: an evidence-based review ALS and other motor neurone disorders. 5, 72-83
11 Simmons Z (2006). Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 11: 257-270
12 Desport JC, Preux PM, Magy L et al (2001). Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. A J Clin Nutrition; 74(3): 328-334
13 Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M (1995). Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. Journal of Neurology; 242(10): 695-8
14 Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P (1999). Nutritional status is a prognostic factor for survival in ALS patients. Neurology; 53(5): 1059-1063
15 Marin B, Desport JC, Kajeu P et al (2011). Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 82(6): 628-34
16 Worwood AM, Leigh PN (1998). Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol 40(3): 159-63
17 Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ (1996). Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr; 63: 130-7
18 Genton L, Viatte V, Janssens JP, Héritier AC, Pichard C (2011). Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clinical Nutrition 30: 553-559
19 Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P (1999). Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53: 1059-63. [2]
20 Stambler N, Charatan M, Cedarbaum JM (1998). Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 50: 66-72
21 Andersen PM, Abrahams S, Borasio GD, Carvalho M, Chio A, Damme PV, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat P, Silani V, Tomik B, Wasner M, Weber M (2012). The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. 2012. ‘EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force’, Eur J Neurol, Vol 19, pp 360-75
22 Silani V, Kasarskis EJ, Yanagisawa N (1998). Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. Journal of Neurology 245 (Suppl 2): S13-9
23 Rio A, Ellis C, Shaw C, Willey E, Ampong MA, Wijesekera L et al (2010). Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease. J Hum Nutr Diet; 23: 408-15
24 Kasarskis EJ, Mendiondo MS, Matthews DE et al (2014). Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin Nutr 2014; 99: 792-803
25 Hardiman O (2000). Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurology 247(4): 245-251
26 Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN et al (2005). EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. European Journal of Neurology; 12: 921-38
27 Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C et al (2015). A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry; 86: 496-501
28 Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2013). Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry; 74: 1258-61
29 National Institute for Health and Care Excellence (2016). Motor Neurone Disease: Assessment and Management. NICE Guidelines [NG42].¬ance/ng42
30 Oliver D, Turner M (2010). Some difficult decisions in ALS/MND. Amyotroph Lateral Scler. August ; 11(4): 339-343
31 Plowman EK (2015). Percutaneous gastrostomy tube placement increases survival in amyotrophic lateral sclerosis. Poster at 2015 Dysphagia Research Society Annual Meeting and Post-Graduate Course.
32 [accessed Oct 2016]
33 Stavroulakis T, Walsh T, Shaw PJ, McDermott CJ (2013). Gastrostomy use in motor neurone disease (MND): a review, meta-analysis and survey of current practice. Amyotroph Lateral Scler Frontotemporal Degener; 14: 96-104
34 ProGas Study Group (2015). Gastrostomy in patients with amyotrophic lateralsclerosis (ProGas): a prospective cohort study. Lancet Neurol 14(7): 702-9

1 Carli F. Physiologic considerations of Enhanced Recovery after Surgery (ERAS) programs: implications of the stress response. Can J Anaesth 2015; 62: 110-9
2 Khoo CK, Vickery CJ, Forsyth N, Vinall NS, Eyre-Brook IA. A postoperative management protocol in patients undergoing elective colorectal resection for cancer. Annals of Surgery. 2007; 245(6): 867-872
3 (2018). Available at: Accessed 10 Sept 2018
5 Weinmann A, Braga M, Harsanyi L et al. ESPEN guidelines on enteral nutrition surgery including organ transplantation. Clinical Nutrition. 2006; 2: 224-244
6 Pascal HE, Teeuwen RP, Bleichrodt C et al. Enhanced Recovery after Surgery (ERAS) versus conventional postoperative care in colorectal surgery. Journal of Gastrointestinal Surgery. 2010; 14(1): 88-95
7 Kehlet H, Wilmore DW (2008). Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248: 189-198
8 Fearon KC, Ljungqvist O, Von Meyenfeldt M et al (2005). Enhanced Recovery After Surgery: a consensus review of clinical care for patients undergoing colonic resection. ClinNutr 24: 466-477
9 Lomer M and Stuart A (2014). Advanced nutrition and dietetics in gastroenterology. Chichester, England: Wiley Blackwell
10 Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo D, Martindale R, Waitzberg D, Bischoff S and Singer P (2017). ESPEN guideline: Clinical nutrition in surgery. Clinical Nutrition, 36(3), pp 623-650

1 Cancer Research UK (2018). Cancer Statistics for the UK. Available at: (accessed: 5th August 2018)
2 International Agency for Research on Cancer (2018). Cancer Today. Available at: (accessed: 23rd August 2018)
3 Gandy J (2014). Manual of Dietetic Practice. 5th Edn. London: The British Dietetic Association
4 Laviano A, Preziosa I, Fanelli FR (2011). Cancer and nutritional status. In: Shaw C (ed) Nutrition and Cancer. Oxford: Wiley Blackwell
5 NHS Wales (2011). Enhanced Recovery After Surgery. Available at: (accessed 2nd February 2012)
6 Royal Surrey County Hospital (2017). Eating well during cancer treatment. Available at (accessed: 10th September 2018)
7 BAPEN (2010). Malnutrition Matters. Available at: (accessed: 21st September 2018)
8 World Cancer Research Fund (2018). Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Available at: (accessed 5th October 2018)

1 Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol. 2012; 46 Suppl: S1-S2
2 Rezac S et al (2018). Fermented foods as a dietary source of live organisms. From Microbiol 9:1785
3 Pen Nutrition - Gastrointestinal System - Microbiota
4 MacDonald D et al (2018). American Gut: an open platform for citizen-science microbe research. Am Soc for Microbiology, May/June 2018. Vol 3 Issue 3. e00031-18
5 McFarland LV et al (2018). Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front Med (Lausanne). 2018; 5: 124
6 Hill C et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepat (2014) 11(8): 506-14.10.1038/nrgastro.2014.66 [PubMed] [Cross Ref]
7 Carrie Dennet. The facts about fermented foods. Today’s Dietitian Vol 20 (4). p 24
8 National Diet and Nutrition Survey Results from Years 7 and 8 (combined) of the Rolling Programme (2014/2015 to 2015/2016.) Public Health England and the Food Standards Agency.

1 National Institute for Health and Clinical Excellence (2008). Irritable bowel syndrome in adults: diagnosis and management. NICE Guideline CG61
2 Nanayakkara WS, Skidmore PM, O’Brien L, Wilkinson TJ, Gearry RB (2016). Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 9:131-142
3 Jones R, Lydeard S. Irritable bowel syndrome in the general population. British Medical Journal 1992; 304: 87-90
4 Tally NJ, Zinmeister AR, van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-934
5 Davies MJ, Heller S, Skinner TC et al (2008). Effectiveness of the diabetes education and self-management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed Type 2 diabetes: cluster randomised controlled trial. BMJ336, 491-495
6 Ringstrom G, Storsrud S and Simren M (2012). A comparison of a short nurse-based and a long multidisciplinary version of structured patient education in irritable bowel syndrome. Eur J Gastroenterol Hepatol 24, 950-957
7 Joyce T, Staudacher H, Whelan K, Irving P and Lomer M (2013). PTH-159 Group education is as effective as one-to-one sessions when administering the low FODMAP diet in functional bowel disorders. Gut, 62 (Suppl 1), pp A276.1-A276
8 Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MCE. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. Volume 28, Issue 6. December 2015. pp 687-696
9 Williams M (2018). Somerset IBS Webinars. CN, pp 53-56

1 A low-FODMAP diet in inflammatory bowel disease (IBD) - an update by Dr Emma Halmos.
2 Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohn’s Colitis. 2009 Feb; 3(1): 8-14
3 Maagaard L1, Ankersen DV1, Végh Z1, Burisch J1, Jensen L1, Pedersen N1, Munkholm P1. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016 Apr 21; 22(15): 4009-19
4 Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 May; 22(5): 1129-36
5 Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohn’s Colitis. 2017 Dec 4; 11(12): 1420-1429
6 Anderson JL, Hedin CR, Benjamin JL, Koutsoumpas A, Ng SC, Hart AL, Forbes A, Stagg AJ, Lindsay JO, Whelan K. Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study. J Crohn’s Colitis. 2015 Nov; 9(11)
7 Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, Burisch J, Andersen JR, Munkholm P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017 May 14; 23(18): 3356-3366
8 Emma P Halmos, Claus T Christophersen, Anthony R Bird, Susan J Shepherd, Jane G Muir and Peter R Gibson. Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016 Apr; 7(4): e164
9 Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F. Beyond Irritable Bowel Syndrome: The Efficacy of the low-FODMAP diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis. 2018; 36(4): 271-280
10 Gibson PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017 Mar; 32 Suppl 1: 40-42
11 Colombel JF, Shin A, Gibson PR. Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 Aug 9. S1542-3565(18)30810-3
12 Barbalho SM, Goulart RA, Aranão ALC, de Oliveira PGC. Inflammatory Bowel Diseases and Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols: An Overview. J Med Food. 2018 Jul 21(7): 633-640
13 BDA: Management of Crohn’s disease - recent developments.

1 Gomes et al (2013). Overcrowding stress decreases macrophage activity and increases salmonella enteritidis invasion in broiler chickens [accessed July 2018 via:]
2 EFSA (2005). Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the European Commission related to treatment of poultry carcasses with chlorine dioxide, acidified sodium chlorite, trisodium phosphate and peroxyacids [accessed July 2018 via:]
3 European Commission. Food Safety: Overview [accessed July 2018 via:]
4 FDA (2017). Steroid Hormone Implants Used for Growth in Food-Producing Animals [accessed July 2018 via:]
5 EFSA (2007). EFSA concludes review of new scientific data on potential risks to human health from certain hormone residues in beef [accessed July 2018 via:]
6 EFSA (2007). Opinion of the scientific panel on contaminants in the food chain on a request from the European Commission related to hormone residues in bovine meat and meat products [accessed July 2018 via:]
7 USDA (2014). Dairy Cattle Management Practices in the United States, 2014 [accessed July 2018 via:]
8 Dohoo et al (2003). A meta-analysis review of the effects of recombinant bovine somatotropin [accessed July 2018 via:]
9 St Pierre et al (2014). Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cows [accessed July 2018 via:]
10 Centner (2016). Efforts to slacken antibiotic resistance: Labelling meat products from animals raised without antibiotics in the United States [accessed July 2018 via:]
11 CDC (2018). About Antimicrobial Resistance [accessed July 2018 via:]
12 FDA (2015). Milk Drug Residue Sampling Survey [accessed July 2018 via:]
13 USDA (2018). Milk Production, Disposition, and Income 2017 Summary [accessed July 2018 via:]
14 Fürstenberger and Senn (2002). Insulin-like growth factors and cancer [accessed July 2018 via:]
15 Dervilly-Pinel et al (2014). Analytical strategies to detect use of recombinant bovine somatotropin in food-producing animals [accessed July 2018 via:]
16 Collier et al (1991). Factors affecting insulin-like growth factor-I concentration in bovine milk [accessed July 2018 via:]
17 Collier and Bauman (2014). Update on human health concerns of recombinant bovine somatotropin use in dairy cows [accessed July 2018 via:]
18 Heaney et al (1999). Dietary Changes Favourably Affect Bone Remodelling in Older Adults [accessed July 2018 via:]
19 Qin et al (2009). Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review [accessed July 2018 via:]
20 American Cancer Society {2014). Recombinant Bovine Growth Hormone [accessed July 2018 via:]
21 Capper et al (2008). The environmental impact of recombinant bovine somatotropin (rbST) use in dairy production [accessed July 2018 via:]
22 European Commission (2005). Ban on antibiotics as growth promoters in animal feed enters into effect [accessed July 2018 via:]
23 FDA (2018). Veterinary Feed Directive (VFD) [accessed July 2018 via:]
24 Alliance to Save our Antibiotics (2018). Comparison of UK and US antibiotic use by farm-animal species [accessed July 2018 via:]
25 Ventola (2015). The Antibiotic Resistance Crisis [accessed July 2018 via:]
26 CDC (2018). Antibiotic / Antimicrobial Resistance (AR / AMR) [accessed July 2018 via:]
27 Silbergeld et al (2008). Industrial Food Animal Production, Antimicrobial Resistance and Human Health [accessed July 2018 via:]
28 WHO (2018). Antibiotic resistance [accessed July 2018 via:]
29 CSPI (2013). Antibiotic Resistance In Foodborne Pathogens [accessed July 2018 via:]
30 Philips et al (2004). Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data” [accessed July 2018 via:]
31 USDA (2015). US National Residue Program for Meat, Poultry, and Egg Products - 2015 Residue Sampling Plans [accessed July 2018 via:]
32 Kilonzo-Nthenge et al (2015). Occurrence and antimicrobial resistance of enterococci isolated from organic and conventional retail chicken [accessed July 2018 via:]
33 USDA Guidelines for Organic Certification of Poultry [accessed July 2018 via:]

1. Aphramor L (2018a). Glossary.
2. N Krieger and S Sidney (1996). Racial discrimination and blood pressure: the CARDIA Study of young black and white adults. Am J Public Health. 86(10): 1370-1378
3. Manual of Dietetic Practice, 5th Edition (2014). Wiley Blackwell. Ed. J Gandy
4. Critical Perspectives in Public Health. Edited By Judith Green, Ronald Labonté (2007). London, Routledge
6. Aphramor L (2018). Key note speaker. 6th Annual Weight Stigma conference, 18-19 June, Leeds Beckett University
7. The Knowing Organisation: How organisations use information to construct meaning, create knowledge and make decisions (2001). Chun Wei Choo. OUP
8. Dietitians for Social Justice
9. Critical Dietetics

2 BDA future workforce
3 A guide to innovative practice placements. BDA Nov 2015
4 Mackenzie M and Newman E (2017). Future proofing the dietetic profession: Exploring social care placements in preregistration dietetic education. International Journal of Practice based learning in Health and Social Care. Vol 5, no 1, pp 65-5. 5. 5.5
7 Health and social care standards: my health, my life. ISBN: 978-1-78851-015-8

1 Corey M et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41(6): 583-91
2 Cystic Fibrosis Trust. UK CF Registry Annual Data Report 2007
3 Cystic Fibrosis Trust. UK Cystic Fibrosis Registry 2017 Annual Data Report
4 Cystic Fibrosis Trust. Nutritional Management of Cystic Fibrosis, 2nd edition, September 2016